CML is commonly detected in tissues of individuals with diabetes and is associated with increased oxidative stress [12]-[14], reduced insulin sensitivity [15], and impaired renal function [11] [16]. The gene discussed is INS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.